CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	3 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Operating expenses:
Research and development	$ 372,600	$ 473,600
General and administrative	1,448,500	797,200
Total operating expenses	1,821,100	1,270,800
Loss from operations	(1,821,100)	(1,270,800)
Other expenses, net:
Interest expense, net	(755,100)	(784,900)
Change in warrant liability	(1,894,700)	(1,727,200)
Loss on extinguishment of debt	(25,050,900)	(768,000)
Loss before income taxes	(29,521,800)	(4,550,900)
Income taxes	(2,300)	(2,400)
Net loss and comprehensive loss	(29,524,100)	$ (4,553,300)
Accrued dividends on Series B Preferred stock	(213,300)
Deemed dividend on Series B Preferred Units	(256,200)
Net loss attributable to common stockholders	$ (29,993,600)	$ (4,553,300)
Basic and diluted net loss attributable to common stockholders per common share	$ (19.23)	$ (3.70)
Weighted average shares used in computing basic and diluted net loss attributable to common stockholders per common share	1,559,483	1,229,488